| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $61.5M | +10.4% |
| SG&A Expense | $18.4M | +25.1% |
| Operating Income | -$79.9M | -13.4% |
| Income Tax | $0 | — |
| Net Income | -$74.4M | -8.7% |
| EPS (Basic) | -$0.98 | +26.3% |
| EPS (Diluted) | -$0.98 | +26.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.1M | +33.7% |
| Short-term Investments | $73.8M | +30.6% |
| Current Assets | $171.1M | +33.0% |
| Total Assets | $175.5M | +32.2% |
| Current Liabilities | $11.9M | +24.0% |
| Total Liabilities | $13.4M | +13.9% |
| Stockholders' Equity | $162.1M | +34.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.1M | -20.4% |
| Investing Cash Flow | -$14.5M | -129.9% |
| Financing Cash Flow | $107.3M | +70.3% |